Cargando…

Resting Heart Rate and the Risk of Microvascular Complications in Patients With Type 2 Diabetes Mellitus

BACKGROUND: A higher resting heart rate is associated with an increased probability of cardiovascular complications and premature death in patients with type 2 diabetes mellitus. The impact of heart rate on the risk of developing microvascular complications, such as diabetic retinopathy and nephropa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hillis, Graham S., Hata, Jun, Woodward, Mark, Perkovic, Vlado, Arima, Hisatomi, Chow, Clara K., Zoungas, Sophia, Patel, Anushka, Poulter, Neil R., Mancia, Giuseppe, Williams, Bryan, Chalmers, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541618/ https://www.ncbi.nlm.nih.gov/pubmed/23316296 http://dx.doi.org/10.1161/JAHA.112.002832

Ejemplares similares

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2017)

The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial
por: Blomster, Juuso I, et al.
Publicado: (2016)

Effects of the Endpoint Adjudication Process on the Results of a Randomised Controlled Trial: The ADVANCE Trial
por: Hata, Jun, et al.
Publicado: (2013)

Associations between body mass index and the risk of renal events in patients with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2018)

Relationship Between Plasma 8‐OH‐Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial
por: Thomas, Merlin C., et al.
Publicado: (2018)

Does Glycemic Control Offer Similar Benefits Among Patients With Diabetes in Different Regions of the World?: Results from the ADVANCE trial
por: Woodward, Mark, et al.
Publicado: (2011)

The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial
por: Nguyen, Tu N., et al.
Publicado: (2021)

History of lower-limb complications and risk of cancer death in people with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2021)

Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial
por: Zoungas, Sophia, et al.
Publicado: (2009)

Effects of Intensive Blood Pressure Lowering on Cardiovascular and Renal Outcomes: A Systematic Review and Meta-Analysis
por: Lv, Jicheng, et al.
Publicado: (2012)

Developing community pharmacists’ role in the management of type 2 diabetes and related microvascular complications: a nationwide survey in Australia
por: Woodhams, Louise, et al.
Publicado: (2023)

Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
por: van der Leeuw, Joep, et al.
Publicado: (2016)

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
por: Mohammedi, Kamel, et al.
Publicado: (2016)

The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study
por: Oshima, Megumi, et al.
Publicado: (2019)

Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor
por: Oshima, Megumi, et al.
Publicado: (2020)

Comparison of Near-Patient Capillary Glucose Measurement and a Risk Assessment Questionnaire in Screening for Type 2 Diabetes in a High-Risk Population in Rural India
por: Ritchie, Georgia E., et al.
Publicado: (2011)

Statistical analysis plan for evaluating low‐ vs. standard‐dose alteplase in the ENhanced Control of Hypertension and Thrombolysis strokE stuDy (ENCHANTED)
por: Anderson, Craig S., et al.
Publicado: (2015)

Effects of the Mediterranean Diet on Cardiovascular Outcomes—A Systematic Review and Meta-Analysis
por: Liyanage, Thaminda, et al.
Publicado: (2016)

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
por: Welsh, Paul, et al.
Publicado: (2018)

The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis
por: Jardine, Meg J, et al.
Publicado: (2012)

The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis
por: Perkovic, Vlado, et al.
Publicado: (2008)

Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy: Results of the ADVANCE study
por: Morton, Jamie, et al.
Publicado: (2012)

New hypoglycemic agents and the kidney: what do the major trials tell us?
por: Smyth, Brendan, et al.
Publicado: (2018)

Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials
por: Heerspink, Hiddo J Lambers, et al.
Publicado: (2009)

Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis
por: Sukkar, Louisa, et al.
Publicado: (2016)

Self‐rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE‐ON trials
por: Hua, X., et al.
Publicado: (2020)

Microvascular Complications in Adolescents with Type 1 Diabetes Mellitus
por: Demirel, Fatma, et al.
Publicado: (2013)

Preventing microvascular complications in type 1 diabetes mellitus
por: Viswanathan, Vijay
Publicado: (2015)

Ultra-low-dose quadruple combination blood pressure–lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol
por: Chow, Clara K., et al.
Publicado: (2021)

The effects of a lifestyle-focused text-messaging intervention on adherence to dietary guideline recommendations in patients with coronary heart disease: an analysis of the TEXT ME study
por: Santo, Karla, et al.
Publicado: (2018)

Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control
por: Tremblay, Johanne, et al.
Publicado: (2021)

Blood pressure: at what level is treatment worthwhile?
por: Atkins, Emily R, et al.
Publicado: (2019)

Cochlear dysfunction and microvascular complications in patients with type 1 diabetes mellitus
por: Felício, João Soares, et al.
Publicado: (2018)

Utilizing Big Data for Public Health
por: Arima, Hisatomi
Publicado: (2016)

Endothelial Dysfunction and Microvascular Complications in Type 1 Diabetes Mellitus
por: Jin, Seon Mi, et al.
Publicado: (2008)

Anemia and Microvascular Complications in Patients With Type 2 Diabetes Mellitus
por: Hosseini, Mahboobeh Sadat, et al.
Publicado: (2014)

Comments on: Microvascular and macrovascular complications in diabetes mellitus: Distinct or continuum?
por: Chauhan, Anubhav, et al.
Publicado: (2016)

Determinants and Stratification of Microvascular Complications of Type 2 Diabetes Mellitus
por: Reddy Mallimala, Priya, et al.
Publicado: (2023)

Inequities in the global representation of sites participating in large, multicentre dialysis trials: a systematic review
por: Smyth, Brendan, et al.
Publicado: (2019)

Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomes
por: Neuen, Brendon L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jubttoesbvc4ofqk709vcsg498